WMGI Wright Medical Group NV

Wright Medical Group N.V. (NASDAQ: WMGI) today announced that the first shoulder arthroplasty procedure was performed using groundbreaking BLUEPRINT Mixed Reality Technology at Mayo Clinic’s campus in Rochester, Minnesota.  Joaquin Sanchez-Sotelo, M.D., Ph.D, performed the procedure utilizing BLUEPRINT OR Visualization Mixed Reality software, which provides a 3-D holographic view of the patient’s pre-operative plan. 

Robert Palmisano, president and chief executive officer of Wright, said, “This procedure is an important milestone for shoulder arthroplasty and marks a major step in the evolution of BLUEPRINT mixed reality technology in shoulder surgery. For the first time in shoulder arthroplasty, surgeons will be able to interact with their 3-D pre-op plan in real-time to more precisely tailor shoulder joint replacement procedures to the unique needs and anatomy of their patients. By integrating other solutions in the future, such as artificial intelligence, case planning optimization and mixed reality modules for medical education, the BLUEPRINT ecosystem offers an opportunity to significantly reduce variability in the way shoulder arthroplasties are performed, potentially reducing complications and improving overall patient outcomes.”

Palmisano continued, “In addition to Dr. Sanchez-Sotelo, we would like to recognize and thank the entire surgeon team who have been integral to the development of this groundbreaking platform: George Athwal – London, ON, CA; Julien Berhouet – Tours, FR; Philippe Collin – Rennes, FR; Ashish Gupta – Brisbane, AU; Gilles Walch – Lyon, FR; and Jon J.P. Warner – Boston, USA.”

The Mixed Reality Application is the latest addition to Wright’s BLUEPRINT ecosystem and enables a surgeon to maintain a direct view of the surgical site and simultaneously visualize and manipulate a holographic representation of the patient’s native anatomy and pre-operative plan. By using hand gestures and voice commands, the surgeon can interact with a more robust data set to optimize the position of the 3-D holographic models displayed by the Mixed Reality application. This can allow the surgeon to replicate the pre-operative plan as closely as possible given the availability of information while operating.

Dr. Sanchez-Sotelo, stated, “I was able to visualize, rotate, and tilt three-dimensional holographic objects right in front of the surgical field. As mixed reality continues to develop, it will provide a very unique, cost-effective tool for execution of our surgical plan.”

Dr. Sanchez-Sotelo and Mayo Clinic have financial interest in Wright Medical Group N.V.  Mayo Clinic will use any revenue it receives to support its not-for-profit mission in patient care, education and research.

For more information on BLUEPRINT, please visit www.shoulderblueprint.com.

Internet Posting of Information

Wright routinely posts information that may be important to investors in the “Investor Relations” section of its website at www.wright.com.  The company encourages investors and potential investors to consult the Wright website regularly for important information about Wright.

About Wright Medical Group N.V.

Wright Medical Group N.V. is a global medical device company focused on extremities and biologics products.  The company is committed to delivering innovative, value-added solutions improving quality of life for patients worldwide and is a recognized leader of surgical solutions for the upper extremity (shoulder, elbow, wrist and hand), lower extremity (foot and ankle) and biologics markets, three of the fastest growing segments in orthopedics.  For more information about Wright, visit www.wright.com.

Cautionary Note Regarding Forward-Looking Statements

This release includes forward-looking statements under the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by words such as “believe,” “expect,” “estimate,” “predict,” “target,” “potential,” “likely,” “continue,” “ongoing,” “could,” “should,” “intend,” “may,” “might,” “plan,” “seek,” “anticipate,” “project” and similar expressions, as well as variations or negatives of these words. Forward-looking statements in this release include, without limitation, statements regarding the performance and market acceptance of the Company’s products and future plans with respect to product development. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties and are cautioned not to place undue reliance on these forward-looking statements. Actual results may differ materially from those currently anticipated due to a number of risks and uncertainties. Applicable risks and uncertainties include, among others, physician acceptance, endorsement, and use of Company products; the effect of regulatory actions, changes in and adoption of reimbursement rates; product liability claims; product recalls; the effects of industry, economic or political conditions outside of the Company’s control; competitor activities; and other risks and uncertainties detailed from time to time in documents filed with the Securities and Exchange Commission (the “SEC”) by the Company, including current reports on Form 8-K, quarterly reports on Form 10-Q and annual reports on Form 10-K. All forward-looking statements are based on information currently available to the Company, and the Company assumes no obligation to update any forward-looking statements. 

Investors & Media: 

Julie D. DeweySr. Vice President, Chief Communications OfficerWright Medical Group N.V.(901) 290-5817julie.dewey@wright.com